Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Clinical trial NCT00516217 · COMPLETED
Trial details
- NCT number
- NCT00516217
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.